Mangili, G <br/><br/>
Octreotide in the management of bowel obstruction in terminal ovarian cancer.  [electronic resource] 

 -  Gynecologic oncology  Jun 1996 
 - 345-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.1996.0154  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Carcinoma--complications<br/>Female<br/>Gastrointestinal Agents--therapeutic use<br/>Humans<br/>Intestinal Obstruction--complications<br/>Intubation, Gastrointestinal<br/>Middle Aged<br/>Octreotide--therapeutic use<br/>Ovarian Neoplasms--complications<br/>Palliative Care<br/>Treatment Outcome<br/>Vomiting--etiology